Zolpidem Tartrate (E5005544 08b9 486e A261 330431fa3c62 01)
Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 68788-8654
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 68788-8654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Im-2 (E5005544 08b9 486e A261 330431fa3c62 02)
Zolpidem Tartrate Er Tab 625mg (E5005544 08b9 486e A261 330431fa3c62 03)
This is a description of a medication called Zolpidem Tartrate ER Tab 6.25mg. It is a controlled substance (C IV) used for treating insomnia. The extended-release tablet contains Zolpidem Tartrate ER 6.25mg. The manufacturer is Lupin Limited. The tablet is round, pink, and marked with LU / E61. It is important to keep this medication out of reach of children and to follow the cautionary warning on its usage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
